As a means of enhancing overall operational capabilities, the PMDA will proactively utilize artificial intelligence (AI) technologies. We have developed the Action Plan for Use of AI in Operations as a guideline for this initiative. For details, please refer to PDF[153KB].
Back
Back
-
Regulations & Services of PMDAInformation about Approved Products in JapanSafety InformationAdvanced Efforts
-
Information for approved products in JapanSafety information
-
Development of Drugs, Medical devices, Regenerative medicines and in Vitro diagnosticsInformation for approved products in JapanRegulatory science
-
Regulations and services of PMDAInformation for approved products in JapanProcedures in JapanAdvanced efforts
Back
-
Regulations and Services of PMDAInformation for apporoved products in JapanSafety informationProcedures in Japan
-
Regulations and Services of PMDAInformation for apporoved products in JapanSafety informationProcedures in Japan
-
Reviews and Related ServicesRegulatory ProceduresPost-marketing Safety Measures
-
Reviews and Related ServicesPost-marketing Safety Measures
- Home
- About PMDA
- Announcements
- Action Plan for the Use of AI in Operations at the PMDA(News Release) (October 10, 2025)
About PMDA